BSX vs DXCM: Fair Value Comparison
BSX's model fair value sits 12.5% above its current price; DXCM's model fair value sits 21.1% below its current price. Of the two, BSX trades further below its model estimate. Model estimates under stated assumptions. Data as of 2026-10-22.
| BSX | DXCM | |
|---|---|---|
| Price | $45.97 | $78.33 |
| Model fair value (multi-method blend) | $51.72 | $61.79 |
| Model fair value differential | +12.5% | -21.1% |
| Methods with a model value above price | 5 of 11 | 9 of 9 |
| Fundamental strength | B+ | A- |
| Next earnings report | 2026-10-28 | 2026-10-29 |
More comparisons
ABT vs BSX · MDT vs BSX · SYK vs BSX · BSX vs EW · ABT vs DXCM · MDT vs DXCM · SYK vs DXCM · EW vs DXCM · All Medical Devices stocks · Compare any two stocks